Metabolism-epigenome crosstalk in physiology and diseases

Journal of Human Genetics

Volumn 58, Issue 7, 2013, Pages 410-415

  Hino, Shinjiro ^a   Nagaoka, Katsuya ^a   Nakao, Mitsuyoshi ^a,b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

DNA methylation; Energy metabolism; Epigenome; Histone modification; Obesity; Warburg effect

Indexed keywords

ENERGY METABOLISM; EPIGENETICS; GENE EXPRESSION; HUMAN; METABOLIC DISORDER; NUTRIENT; OBESITY; PATHOGENESIS; PHENOTYPE; PHYSIOLOGY; REVIEW;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; OBESITY;

EID: 84880909811     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2013.57     Document Type: Review

References (62)

1. Mohyeldin, A., Garzon-Muvdi, T. & Quinones-Hinojosa, A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 7, 150-161 (2010
2. Desvergne, B., Michalik, L. & Wahli, W. Transcriptional regulation of metabolism. Physiol. Rev. 86, 465-514 (2006
3. Kaochar, S. & Tu, B. P. Gatekeepers of chromatin: Small metabolites elicit big changes in gene expression. Trends. Biochem. Sci. 37, 477-483 (2012
4. Tseng, Y. H., Cypess, A. M. & Kahn, C. R. Cellular bioenergetics as a target for obesity therapy. Nat. Rev. Drug. Discov. 9, 465-482 (2010
5. Ward, P. S. & Thompson, C. B. Metabolic reprogramming: A cancer hallmark even warburg did not anticipate. Cancer cell 21, 297-308 (2012
6. Hanson, M. A. & Gluckman, P. D. Developmental origins of health and disease: New insights. Basic. Clin. Pharmacol. Toxicol. 102, 90-93 (2008
7. Jimenez-Chillaron, J. C., Diaz, R., Martinez, D., Pentinat, T., Ramon-Krauel, M., Ribo, S. et al. The role of nutrition on epigenetic modifications and their implications on health. Biochimie 94, 2242-2263 (2012
8. Suva, M. L., Riggi, N. & Bernstein, B. E. Epigenetic reprogramming in cancer. Science 339, 1567-1570 (2013
9. Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479-483 (2012
10. Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H. et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326-1338 (2012
11. Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41-45 (2000
12. Latchman, D. S. Gene control (Garland Science, 2010
13. Anderson, O. S., Sant, K. E. & Dolinoy, D. C. Nutrition and epigenetics: An interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J. Nutr. Biochem. 23, 853-859 (2012
14. Bernal, A. J. & Jirtle, R. L. Epigenomic disruption: The effects of early developmental exposures. Birth Defects Res. A Clin. Mol. Teratol. 88, 938-944 (2010
15. Wolff, G. L., Kodell, R. L., Moore, S. R. & Cooney, C. A. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. Faseb J. 12, 949-957 (1998
16. Pedersen, M. T. & Helin, K. Histone demethylases in development and disease. Trends. Cell. Biol. 20, 662-671 (2010
17. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J R., Cole, P. A. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953 (2004
18. Karytinos, A., Forneris, F., Profumo, A., Ciossani, G., Battaglioli, E., Binda, C. et al. A novel mammalian flavin-dependent histone demethylase. J. Biol. Chem. 284, 17775-17782 (2009
19. Barile, M., Brizio, C., Valenti, D., De Virgilio, C. & Passarella, S. The riboflavin/FAD cycle in rat liver mitochondria. Eur. J. Biochem. 267, 4888-4900 (2000
20. Tsukada, Y., Fang, J., Erdjument-Bromage, H., Warren, M. E., Borchers, C. H., Tempst, P. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811-816 (2006
21. Wu, H. & Zhang, Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 25, 2436-2452 (2011
22. Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell. Biol. 13, 225-238 (2012
23. Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R. & Thompson, C. B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076-1080 (2009
24. Mootha, V. K., Lindgren, C. M., Eriksson, K. F., Subramanian, A., Sihag, S., Lehar, J. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003
25. Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 100, 8466-8471 (2003
26. Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950 (2002
27. Hales, C. N. & Barker, D. J. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 35, 595-601 (1992
28. Gluckman, P. D., Hanson, M. A., Buklijas, T., Low, F. M. & Beedle, A. S. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat. Rev. Endocrinol. 5, 401-408 (2009
29. Turner, N. & Heilbronn, L. K. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol. Metab. 19, 324-330 (2008
30. Barres, R., Osler, M. E., Yan, J., Rune, A., Fritz, T., Caidahl, K. et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell. Metab. 10, 189-198 (2009
31. Houten, S. M. & Auwerx, J. PGC-1alpha: Turbocharging mitochondria. Cell 119, 5-7 (2004
32. Brons, C., Jacobsen, S., Nilsson, E., Ronn, T., Jensen, C. B., Storgaard, H. et al. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J. Clin. Endocrinol. Metab. 95, 3048-3056 (2010
33. Sanyal, A. J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K. et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183-1192 (2001
34. Sookoian, S., Rosselli, M. S., Gemma, C., Burgueno, A. L., Fernandez Gianotti, T., Castano, G. O. et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferatoractivated receptor gamma coactivator 1alpha promoter. Hepatology 52, 1992-2000 (2010
35. Mattson, M. P. Gene-diet interactions in brain aging and neurodegenerative disorders. Ann. Intern. Med. 139, 441-444 (2003
36. Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L. et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci. Transl. Med. 2, 52ra73 (2010
37. Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T. & Brinton, R. D. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 106, 14670-14675 (2009
38. Gesta, S., Tseng, Y. H. & Kahn, C. R. Developmental origin of fat: Tracking obesity to its source. Cell 131, 242-256 (2007
39. Yamauchi, T., Oike, Y., Kamon, J., Waki, H., Komeda, K., Tsuchida, A. et al. Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nat. Genet. 30, 221-226 (2002
40. Tateishi, K., Okada, Y., Kallin, E. M. & Zhang, Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458, 757-761 (2009
41. Inagaki, T., Tachibana, M., Magoori, K., Kudo, H., Tanaka, T., Okamura, M. et al. Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice. Genes Cells 14, 991-1001 (2009
42. Kamei, Y., Suganami, T., Ehara, T., Kanai, S., Hayashi, K., Yamamoto, Y. et al. Increased expression of DNA methyltransferase 3a in obese adipose tissue: Studies with transgenic mice. Obesity (Silver Spring) 18, 314-321 (2010
43. Ehara, T., Kamei, Y., Takahashi, M., Yuan, X., Kanai, S., Tamura, E. et al. Role of DNA methylation in the regulation of lipogenic glycerol-3-phosphate acyltransferase 1 gene expression in the mouse neonatal liver. Diabetes 61, 2442-2450 (2012
44. Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K. et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-Activating epigenetic marks that coexist on the lysine tail. Diabetes 58, 1229-1236 (2009
45. El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409-2417 (2008
46. Hino, S., Sakamoto, A., Nagaoka, K., Anan, K., Wang, Y., Mimasu, S. et al. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nat. Commun. 3, 758 (2012
47. Wang, X. & Jin, H. The epigenetic basis of the Warburg effect. Epigenetics 5, 566-568 (2010
48. Chen, M., Zhang, J., Li, N., Qian, Z., Zhu, M., Li, Q. et al. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One 6, e25564 (2011
49. Sebastian, C., Zwaans, B. M., Silberman, D. M., Gymrek, M., Goren, A., Zhong, L. et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151, 1185-1199 (2012
50. Donohoe, D. R., Garge, N., Zhang, X., Sun, W., O'Connell, T. M., Bunger, M. K. et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell. Metab. 13, 517-526 (2011
51. Davie, J. R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133, 2485S-2493S (2003
52. Andriamihaja, M., Chaumontet, C., Tome, D. & Blachier, F. Butyrate metabolism in human colon carcinoma cells: Implications concerning its growth-inhibitory effect. J. Cell. Physiol. 218, 58-65 (2009
53. Lupton, J. R. Microbial degradation products influence colon cancer risk: The butyrate controversy. J. Nutr. 134, 479-482 (2004
54. Donohoe, D. R., Collins, L. B., Wali, A., Bigler, R., Sun, W. & Bultman, S. J. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell. 48, 612-626 (2012
55. Ichimura, K. Molecular pathogenesis of IDH mutations in gliomas. Brain. Tumor. Pathol. 29, 131-139 (2012
56. Rakheja, D., Konoplev, S., Medeiros, L. J. & Chen, W. IDH mutations in acute myeloid leukemia. Hum. Pathol. 43, 1541-1551 (2012
57. Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M. et al. Cancer-Associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744 (2009
58. Chowdhury, R., Yeoh, K. K., Tian, Y. M., Hillringhaus, L., Bagg, E. A., Rose, N. R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO. Rep. 12, 463-469 (2011
59. Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S. H. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer cell 19, 17-30 (2011
60. Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer cell 18, 553-567 (2010
61. Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K. et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150, 1135-1146 (2012
62. Losman, J. A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C. et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339, 1621-1625 (2013